Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Vapreotide, RC-3940-II and cetrorelix: novel peptide analogues for treating renal cell carcinoma

June 11, 1998

Miravant and Xillix Technologies enter early-stage cancer collaboration

June 10, 1998

GlycoDesign starts phase II trial of GD0039 for the treatment of RCC

June 10, 1998

Clinical trial results for DUROS leuprolide implant announced at AUA meeting

June 10, 1998

No-approval recommendation given for AD-32 by FDA advisory committee

June 9, 1998

Antitumor, antifungal cryptophycins developed by U.S. pharmaceutical/academic team

June 9, 1998

BMS prepares novel sulfenamide taxane derivatives

June 9, 1998

17beta-HSD type 1 inhibitors: a new treatment option for hormone-dependent breast cancer

June 9, 1998

Flavopiridol induces apoptosis, regression of human hematological malignancies

June 9, 1998

Argonex raises funds for cancer vaccine programs

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...